Clicky

Talaris Therapeutics, Inc.(TALS)

Description: Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing an innovative method of allogeneic hematopoietic stem cell transplantation with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and metabolic disorders. Talaris maintains corporate offices in Boston, Mass., and its cell processing facility in Louisville, Ky


Keywords: Clinical Medicine Stem Cell Cell Therapy Transplantation Transplantation Medicine Hematopoietic Stem Cell Allotransplantation Hematopoietic Stem Cell Transplantation Shimon Slavin Primary Immunodeficiency

Home Page: talaristx.com

TALS Technical Analysis

570 South Preston Street
Louisville, KY 40202
United States
Phone: 502 398 9250


Officers

Name Title
Mr. Scott Requadt J.D., L.L.B., M.B.A., MBA Pres, CEO, Sec. & Director
Dr. Suzanne T. Ildstad M.D. Founder, Member of Scientific Advisory Board, Sr. Scientific Advisor & Director
Ms. Nancy Krieger M.D. Chief Medical Officer
Ms. Mary Kay Fenton CFO & Treasurer
Mr. Michael Zdanowski Chief Technology Officer
Ms. Suzanne Tollerud VP of Corp. Devel.
Mr. Andrew Clyde Farnsworth Chief HR Officer
Mr. Eric Gornstein Head of New Product Planning
Ms. Farah Natoli Head of Portfolio & Program Management
Mr. Colby Suire Ph.D. Head of R&D

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.2762
Price-to-Sales TTM: 0
IPO Date: 2021-05-07
Fiscal Year End: December
Full Time Employees: 131
Back to stocks